GlassScriptPhysician profile
Jamil Kendall
NPI 1508360819
$17,279.08
in general payments reported to CMS, 2019-2025
14 companies · $2,465 in 2025
The $2,465 reported for 2025 was more than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $186 · 2023: $6,043 · 2024: $8,584 · 2025: $2,465.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,671 · Education: $4,167 · Grant: $4,167 · Travel and Lodging: $2,414 · Consulting Fee: $675.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,670.58 |
| Education | $4,166.67 |
| Grant | $4,166.67 |
| Travel and Lodging | $2,413.86 |
| Consulting Fee | $675.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $8,354.08 | 2023-2024 | Real Intelligence |
| Stryker Corporation | $3,853.06 | 2022-2025 | Mako, Pangea, Insignia |
| Medical Device Business Services, INC. | $1,528.29 | 2024-2025 | Velys, Na |
| Linkbio Corp | $861.40 | 2023 | |
| Zimmer Biomet Holdings, INC. | $845.81 | 2023-2024 | Avenir, G7, Oss Orthopedic Salvage System |
| Orthalign INC | $468.53 | 2023-2024 | Orthalign Plus |
| Medtronic, INC. | $460.02 | 2022-2024 | Aquamantys(Tm), Plasmablade(Tm) |
| Depuy Synthes Sales INC. | $329.10 | 2024-2025 | Actis, Na |
| Omnilife Science, INC | $162.45 | 2023-2025 | Omnibotics 3.0, Various Products |
| Globus Medical, INC. | $159.27 | 2024 | Evo Retrograde |
| Organogenesis INC. | $115.34 | 2025 | Puraply Wound Matrix |
| Davol INC. | $99.83 | 2023 | Arista Ah Flexitip |
| Uoc USA INC | $23.58 | 2024 | Psa, Locking Cage and Ustar II |
| Moximed, INC | $18.32 | 2025 | Misha Knee System, Small, Left |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jamil Kendall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.